Mysimba is a drug for weight control in adults (18 years and older). It is used in addition to a low-calorie diet and physical activity.

Indications for use:

• obesity (BMI ≥ 30 kg/m²);
• overweight (BMI between 27 and 30 kg/m²) in the presence of concomitant diseases such as type 2 diabetes, dyslipidemia, or controlled hypertension.

Important: Misimba does not promise rapid weight loss. Its effectiveness increases when combined with physical activity and proper nutrition.

Contraindications

It is not recommended to take Misimba if you have:

• severe liver disease;
• cancer of the central nervous system;
• uncontrolled hypertension;
• severe renal failure;
• recent alcohol withdrawal;
• recent opioid withdrawal in drug addicts;
• epilepsy;
• bipolar disorder;
• nervous bulimia;
• taking bupropion;
• nervous anorexia;
• mental disorders;
• dependence on certain medications.

The drug is contraindicated for pregnant, planning pregnancy and lactating women.

Method of application and doses

The dosage is strictly regulated. Start with the minimum dose, gradually increasing it. The maximum daily dose is four tablets (two in the morning and evening). The tablets are taken whole, without chewing or crushing, preferably with food.

After 16 weeks of treatment, its effectiveness is evaluated. If the weight loss is less than 5% of the initial weight, the therapy is discontinued.

For patients with mild liver impairment or moderate/severe renal insufficiency, the maximum daily dose is two tablets.

Side effects

Common side effects include:

• nausea and vomiting;
• constipation;
• dizziness;
• dry mouth;
• insomnia;
• anxiety;
• headaches;
• muscle and joint pain.